Fig. 4
From: Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Reprinted with permission [61]. Copyright 2021, The Author(s)
 A Expressions of TNFα (M1 marker) and DC-SIGN (M2 marker) measured by RT-qPCR in THP-1 macrophages treated with ZVI-NPs. B Immunofluorescent staining of macrophages in tumor tissue sections. C Tumor volume changes of different groups. D The proportions of different T cells in tumors analyzed by flow cytometry analysis.